originally posted by SFJoe:
The profitability of vaccines is highly variable. With the vaccine court in place and higher prices, new vaccines make money. Old legacy vaccines are very difficult to manufacture, actually practically all vaccines are tough to make, and the prices of the old ones generate margins that are worse than for most things pharma sells.
I have raised money for vaccine discovery and development companies, and I would tell you that in many cases it is uphill. There is a perception in many parts of pharma and finance that the vaccine business is one you don't want to touch--you give the product to healthy people, so the safety barrier to license is very high, the FDA is perceived as being an irreducible risk.
The politics around vaccines are also a drag.
So there are actually a bunch of companies and funders that want nothing to do with them.
Thanks for this -- I would be curious to hear more at some point. It does make the politics of this vaccine business more interesting. No doubt I've jumped to conclusions based on news reports like this.